Table 2. Predicted proportions of acinar types for HGD/EAC cases, controls, and the non-EAC esophagectomy group.
HGD/EAC Cases |
Controls | Non-EAC | P-Values | |||
---|---|---|---|---|---|---|
EAC vs. Controls |
Non-EAC vs. Controls |
Non-EAC vs. EAC |
||||
Dilated | 11.6% | 5.8% | 21.9% | 0.05 | <0.001 | <0.001 |
Ductular Metaplasia | 12.7% | 3.5% | 4.3% | 0.006 | 0.001 | 0.19 |
Oncocytic | 1.0% | 6.7% | 2.6% | 0.005 | 0.19 | 0.01 |
Serous | 7.9% | 10.8% | 0.9% | reference | reference | reference |